Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-30 @ 12:00 AM
Study NCT ID:
NCT07359404
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2026-01-22
First Post:
2025-12-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC
Sponsor:
Organization: